Evidence map›Paper›PMID 27550350›Full record

ArticleAntimicrobial agents and chemotherapy2016

Transposon-Sequencing Analysis Unveils Novel Genes Involved in the Generation of Persister Cells in Uropathogenic Escherichia coli.

Roberto C Molina-Quiroz, David W Lazinski, Andrew Camilli, Stuart B Levy

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Staying in the loop to make ends meet: roles and regulation of GlmR inbioRxiv : the preprint server for biology · 2025
    Article
  5. Article
  6. Identifying essential genes inJournal of bacteriology · 2025
    Article
  7. Bacterial persisters: molecular mechanisms and therapeutic development.Signal transduction and targeted therapy · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Roberto C Molina-QuirozCenter for Adaptation Genetics and Drug Resistance, Tufts University School of Medicine, Boston, Massachusetts, USA.
David W LazinskiDepartment of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, USA.
Andrew CamilliDepartment of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, USA.
Stuart B LevyCenter for Adaptation Genetics and Drug Resistance, Tufts University School of Medicine, Boston, Massachusetts, USA stuart.levy@tufts.edu.
Tufts University · USHoward Hughes Medical Institute · US

Funding

The multiple antibiotic resistance (MAR)regulonR01AI056021 · NIAID · TUFTS UNIVERSITY BOSTON · PI LEVY, STUART B. · 2003 to 2017
$8.9M
NIAID NIH HHS R01 AI056021
6 · The paper itself

Abstract

Persister cells are highly tolerant to different antibiotics and are associated with relapsing infections. In order to understand this phenomenon further, we exposed a transposon library to a lethal concentration of ampicillin, and mutants that survived were identified by transposon sequencing (Tn-Seq). We determined that mutations related to carbon metabolism, cell envelope (cell wall generation and membrane proteins), and stress response have a role in persister cell generation.

Indexed as

AmpicillinAnti-Bacterial AgentsDNA Transposable ElementsEscherichia coli ProteinsGene Expression Regulation, BacterialMicrobial Sensitivity TestsMutationUropathogenic Escherichia coliAmpicillinAnti-Bacterial AgentsDNA Transposable ElementsEscherichia coli Proteins

Identifiers

PMID27550350
PMCPMC5075105
OpenAlexW2513838027

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.